Nexgel (NXGL) director Henry sells $18,148 in shares
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nexgel Inc (NXGL)
Nexgel Inc stock price live, this page displays NASDAQ NXGL stock exchange data. View the NXGL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nexgel Inc real time stock price chart below.
What Is the Nexgel Inc Stock Price Today?
The Nexgel Inc stock price today is 2.600.
What Is the Stock Symbol for Nexgel Inc?
The stock symbol for Nexgel Inc is ""NXGL.""
What Stock Exchange Does Nexgel Inc Trade On?
Nexgel Inc is listed and trades on the NASDAQ stock exchange.
Is Nexgel Inc a Good Stock to Buy?
Determining whether Nexgel Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NXGL quote. (ISIN: US65344E1073)
What Is the Nexgel Inc Stock Price Today?
The Nexgel Inc stock price today is 2.600.
What Is the Stock Symbol for Nexgel Inc?
The stock symbol for Nexgel Inc is ""NXGL.""
What Stock Exchange Does Nexgel Inc Trade On?
Nexgel Inc is listed and trades on the NASDAQ stock exchange.
Is Nexgel Inc a Good Stock to Buy?
Determining whether Nexgel Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NXGL quote. (ISIN: US65344E1073)
NASDAQ
Currency in USD
Fair Value
An estimate of a Nexgel's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.362
2.680
52 wk Range
2.100
5.100
NXGL Scorecard
Full Analysis
Quickly burning through cash
Unusual trading volume
1/2
Fair Value
An estimate of a Nexgel's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.3622.680
52 wk Range
2.1005.100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NXGL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Nexgel's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
6.000
Upside
+130.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Nexgel CEO Adam Levy sells $4,613 in common stock
- Investing.com
- Nexgel (NXGL) director Henry sells $18,148 in shares
- Investing.com
- Form 8K Nexgel Inc For: 14 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Nexgel Inc Company Profile
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Nexgel Inc Earnings Call Summary for Q2/2025
- Q2 revenue doubled YoY to $2.9M, missing $3.08M forecast; EPS at -$0.09 vs -$0.05 expected; stock up 2.26% post-earnings
- Gross margin improved to 43.6% from 20.3% in Q2 2024; adjusted EBITDA loss narrowed to -$420,000 from -$790,000
- 2025 revenue guidance set at $13M; company aims for positive EBITDA by year-end; Silly George brand expected to contribute $6-6.5M
- CEO emphasizes growth potential and resilience in recession; exploring new retail and private label opportunities
- Risks include tariff impacts, delays in AbbVie project (now 2026), high reliance on Silly George brand, and macroeconomic pressures
Last Updated: 12/08/2025, 22:26
Read Full TranscriptCompare NXGL to Peers and Sector
Metrics to compare | NXGL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNXGLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.2x | −10.4x | −0.7x | |
PEG Ratio | −0.22 | −0.01 | 0.00 | |
Price/Book | 4.5x | 1.2x | 2.6x | |
Price / LTM Sales | 1.8x | 3.9x | 3.4x | |
Upside (Analyst Target) | 154.2% | 48.4% | 37.6% | |
Fair Value Upside | Unlock | 7.7% | 5.3% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.000
(+130.77% Upside)
Earnings
Latest Release
Aug 12, 2025
EPS / Forecast
-0.09 / -0.05
Revenue / Forecast
2.88M / 3.08M
People Also Watch
FAQ
What Stock Exchange Does Nexgel Trade On?
Nexgel is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Nexgel?
The stock symbol for Nexgel is "NXGL."
What Is the Nexgel Market Cap?
As of today, Nexgel market cap is 19.04M.
What Is Nexgel's Earnings Per Share (TTM)?
The Nexgel EPS (TTM) is -0.40.
When Is the Next Nexgel Earnings Date?
Nexgel will release its next earnings report on 17 Nov 2025.
From a Technical Analysis Perspective, Is NXGL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Nexgel Stock Split?
Nexgel has split 0 times.
How Many Employees Does Nexgel Have?
Nexgel has 19 employees.
What is the current trading status of Nexgel (NXGL)?
As of 17 Oct 2025, Nexgel (NXGL) is trading at a price of 2.600, with a previous close of 2.36. The stock has fluctuated within a day range of 2.362 to 2.680, while its 52-week range spans from 2.100 to 5.100.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.